These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Small mutation screening in the DMD gene by whole exome sequencing of an argentine Duchenne/Becker muscular dystrophies cohort. Luce LN; Carcione M; Mazzanti C; Ferrer M; Szijan I; Giliberto F Neuromuscul Disord; 2018 Dec; 28(12):986-995. PubMed ID: 30342905 [TBL] [Abstract][Full Text] [Related]
24. Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing. Han S; Xu H; Zheng J; Sun J; Feng X; Wang Y; Ye W; Ke Q; Ren Y; Yao S; Zhang S; Chen J; Griggs RC; Zhao Z; Qi M; Gatheridge MA Biomed Res Int; 2020; 2020():8396429. PubMed ID: 33029525 [TBL] [Abstract][Full Text] [Related]
25. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Hauser E; Toifl K; Mad A; Bittner R Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369 [TBL] [Abstract][Full Text] [Related]
26. Is it the right time for an infant screening for Duchenne muscular dystrophy? Vita GL; Vita G Neurol Sci; 2020 Jul; 41(7):1677-1683. PubMed ID: 32112218 [TBL] [Abstract][Full Text] [Related]
27. Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care. Armstrong N; Schrader R; Fischer R; Crossnohere N Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):162-168. PubMed ID: 35932090 [TBL] [Abstract][Full Text] [Related]
28. Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients. Zhang Y; Yang W; Wen G; Wu Y; Jing Z; Li D; Tang M; Liu G; Wei X; Zhong Y; Li Y; Deng Y Mol Genet Genomic Med; 2019 May; 7(5):e622. PubMed ID: 30938079 [TBL] [Abstract][Full Text] [Related]
29. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Drousiotou A; Ioannou P; Georgiou T; Mavrikiou E; Christopoulos G; Kyriakides T; Voyasianos M; Argyriou A; Middleton L Genet Test; 1998; 2(1):55-60. PubMed ID: 10464597 [TBL] [Abstract][Full Text] [Related]
30. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup. Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761 [TBL] [Abstract][Full Text] [Related]
33. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy. Helderman-van den Enden AT; Madan K; Breuning MH; van der Hout AH; Bakker E; de Die-Smulders CE; Ginjaar HB Eur J Hum Genet; 2013 Jan; 21(1):21-6. PubMed ID: 22669413 [TBL] [Abstract][Full Text] [Related]
34. Newborn screening for Duchenne muscular dystrophy gains support: researchers to push for federal recommendation to have states add DMD test to newborn panel. Levenson D Am J Med Genet A; 2012 Dec; 158A(12):viii-ix. PubMed ID: 23174945 [No Abstract] [Full Text] [Related]
35. Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays. Dantonio P; Tavakoli NP; Migliore B; McCown E; Lim T; Park S; Caggana M; Kucera KS; Phan H; Street N; Petritis K; Vogt RF Int J Neonatal Screen; 2023 Feb; 9(1):. PubMed ID: 36975851 [TBL] [Abstract][Full Text] [Related]
36. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277 [TBL] [Abstract][Full Text] [Related]
37. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States. Ross LF; Clarke AJ Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012 [TBL] [Abstract][Full Text] [Related]
38. Improving recognition of Duchenne muscular dystrophy: a retrospective case note review. van Ruiten HJ; Straub V; Bushby K; Guglieri M Arch Dis Child; 2014 Dec; 99(12):1074-7. PubMed ID: 25187493 [TBL] [Abstract][Full Text] [Related]
39. Dystrophin Protein Quantification as a Duchenne Muscular Dystrophy Diagnostic Biomarker in Dried Blood Spots Using Multiple Reaction Monitoring Tandem Mass Spectrometry: A Preliminary Study. Nimer RM; Sumaily KM; Almuslat A; Abdel Jabar M; Sabi EM; Al-Muhaizea MA; Abdel Rahman AM Molecules; 2022 Jun; 27(12):. PubMed ID: 35744792 [TBL] [Abstract][Full Text] [Related]
40. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015. Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E; Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]